Antiplatelet Activity of Tetramethylpyrazine via Regulation of the P2Y12 Receptor Downstream Signaling Pathway

<div>Experimental plan for the assessment of P2Y<sub>12</sub> receptor-mediated platelet activation during TMP treatment.</div>

Evidence-Based Complementary and Alternative Medicine

Figure 1: Antiplatelet Activity of Tetramethylpyrazine via Regulation of the P2Y12 Receptor Downstream Signaling Pathway 